Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;28(10):103754.
doi: 10.1016/j.drudis.2023.103754. Epub 2023 Aug 28.

SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy

Samarth Dwivedi  1 , Atharva Chavan  1 , Atish T Paul  2
Affiliations
Review

SET7, a lysine-specific methyl transferase: An intriguing epigenetic target to combat diabetic nephropathy

Samarth Dwivedi et al. Drug Discov Today. 2023 Oct.

Abstract

Diabetic nephropathy (DN) is a dreadful complication of diabetes that affects ∼50% of diabetics and is a leading cause of end-stage renal disease (ESRD). Studies have linked aberrant expression of lysine methyltransferases (KMTs) to the onset and progression of DN. SET7 is a KMT that methylates specific lysine residues of the histone and nonhistone proteins. It plays an important role in the transforming growth factor-β (TGF-β)-induced upregulation of extracellular matrix (ECM)-associated genes that are responsible for the inflammatory cascade observed in DN. Inhibiting SET7 has potential to attenuate renal disorders in animal studies. This review will focus on the role of SET7 in DN and its potential as a therapeutic target to combat DN.

Keywords: Diabetic nephropathy; Histone, nonhistone; Lysine methylation; SET7; SET7 inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Publication types

LinkOut - more resources